HER2+ breast cancer treatment and cardiotoxicity: monitoring and management

BACKGROUND: Breast cancer is a leading cause of death for women worldwide, with incidence increasing in lower-income countries. For patients with human epidermal growth factor receptor-2-positive (HER2+) breast cancer, widespread availability of several agents targeting the HER2 receptor has resulte...

Descripción completa

Detalles Bibliográficos
Autores principales: Jerusalem, Guy, Lancellotti, Patrizio, Kim, Sung-Bae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661020/
https://www.ncbi.nlm.nih.gov/pubmed/31165940
http://dx.doi.org/10.1007/s10549-019-05303-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661020/
https://www.ncbi.nlm.nih.gov/pubmed/31165940
http://dx.doi.org/10.1007/s10549-019-05303-y

Ejemplares similares